Olanzapine LAI FDA Approval: How the Israeli‑French Alliance Seizes a $5 B Schizophrenia Market
Explore how the FDA’s approval of olanzapine LAI boosts the Israeli‑French partnership’s market reach, pricing power, and digital adherence strategy.
5 minutes to read